ICON Reports First Quarter 2019 Results

16:15 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Highlights Net business wins (including pass-through) in the quarter of $885 million; a book to bill of 1.31. Closing backlog (including pass-through) of $7.9 billion, a year on year i...

Other Sources for this Article

ICON plc Contact:
Investor Relations +1 888 381 7923 or
Brendan Brennan, Chief Financial Officer +353 1 291 2000
Jonathan Curtain, Vice President Corporate Finance & Investor Relations +353 1 291 2000


More From BioPortfolio on "ICON Reports First Quarter 2019 Results"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...